Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Valneva
Pharma
After lifting pause, FDA suspends use of Valneva's Ixchiq
Less than three weeks after lifting a pause on the use of Valneva’s chikungunya vaccine Ixchiq, the FDA has banned the use of the shot in the U.S.
Kevin Dunleavy
Aug 25, 2025 11:29am
FDA lifts pause of Valneva's chikungunya vaccine in older adults
Aug 7, 2025 10:42am
FDA, CDC call for pause of chikungunya shot rollout in seniors
May 12, 2025 9:52am
France suspends use of Valneva chikungunya shot in older adults
Apr 28, 2025 10:35am
Bavarian Nordic's chikungunya vaccine wins broad FDA approval
Feb 18, 2025 4:45pm
Valneva nabs $33M US supply pact for Japanese encephalitis shot
Feb 3, 2025 11:32am
